$32.74
1.24%
NYSE, Sep 17, 01:19 pm EDT. Market open.
ISIN
US6877931096
Symbol
OSCR
Sector
Industry

Oscar Health Target price 2026 - Analyst rating & recommendation

Oscar Health Classifications & Recommendation

Buy
47%
Hold
47%
Sell
5%

Oscar Health Price Target

Target Price $29.07
Price $32.34
Deviation
Number of Estimates 14
14 Analysts have issued a price target Oscar Health 2027 . The average Oscar Health target price is $29.07. This is lower than the current stock price. The highest price target is , the lowest is .
A rating was issued by 19 analysts: 9 Analysts recommend Oscar Health to buy, 9 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Oscar Health stock has an average upside potential 2027 of . Most analysts recommend the Oscar Health stock at Buy or hold.

Sales and Margin forecast 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Revenue Billion $ 11.70 19.13
27.50% 63.47%
EBITDA Margin -3.14% 3.67%
422.35% 216.86%
Net Margin -3.79% 2.65%
1,466.76% 169.97%

14 Analysts have issued a sales forecast Oscar Health 2026 . The average Oscar Health sales estimate is

$19.1b
unlock
. This is
24.87% higher
unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$19.8b 29.21%
unlock
, the lowest is
$18.0b 17.56%
unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2025 $11.7b 27.50%
2026
$19.1b 63.47%
unlock
2027
$20.8b 8.89%
unlock
2028
$23.0b 10.31%
unlock
2029
$25.8b 12.38%
unlock
2030
$28.8b 11.52%
unlock

14 Analysts have issued an Oscar Health EBITDA forecast 2026. The average Oscar Health EBITDA estimate is

$702m
unlock
. This is
6.74% higher
unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$845m 28.35%
unlock
, the lowest is
$456m 30.74%
unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2025 $-367m 510.99%
2026
$702m 291.13%
unlock
2027
$824m 17.34%
unlock
2028
$1.1b 35.77%
unlock
2029
$1.2b 8.40%
unlock

EBITDA Margin

2025 -3.14% 422.35%
2026
3.67% 216.86%
unlock
2027
3.96% 7.90%
unlock
2028
4.87% 22.98%
unlock
2029
4.70% 3.49%
unlock

14 Oscar Health Analysts have issued a net profit forecast 2026. The average Oscar Health net profit estimate is

$508m
unlock
. This is
7.83% lower
unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$649m 17.86%
unlock
, the lowest is
$281m 48.93%
unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2025 $-443m 1,842.63%
2026
$508m 214.55%
unlock
2027
$575m 13.35%
unlock
2028
$775m 34.69%
unlock
2029
$825m 6.42%
unlock
2030
$888m 7.63%
unlock

Net Margin

2025 -3.79% 1,466.76%
2026
2.65% 169.97%
unlock
2027
2.76% 4.15%
unlock
2028
3.37% 22.10%
unlock
2029
3.19% 5.34%
unlock
2030
3.08% 3.45%
unlock

Earnings per share, P/E ratio and EV/sales Estimates 2026, 2027 to 2030

Create a premium account to unlock analyst estimates. Learn more

Select at least one metric to display the chart.


Quarter Annually
Dec '25 2026
Estimates
Earnings Per Share $ -1.69 1.64
1,790.00% 197.04%
P/E 19.66
EV/Sales 0.32

14 Analysts have issued a Oscar Health forecast for earnings per share. The average Oscar Health EPS is

$1.64
unlock
. This is
0.61% lower
unlock
than earnings per share in the financial year 2025. The highest EPS forecast is
$2.10 27.27%
unlock
, the lowest is
$0.91 44.85%
unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2025 $-1.69 1,790.00%
2026
$1.64 197.04%
unlock
2027
$1.86 13.41%
unlock
2028
$2.51 34.95%
unlock
2029
$2.67 6.37%
unlock
2030
$2.88 7.87%
unlock

P/E ratio

Current 19.60 163.88%
2026
19.66 0.31%
unlock
2027
17.35 11.75%
unlock
2028
12.88 25.76%
unlock
2029
12.10 6.06%
unlock
2030
11.24 7.11%
unlock

Based on analysts' sales estimates for 2026, the Oscar Health stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 0.40 60.00%
2026
0.32 20.20%
unlock
2027
0.29 8.15%
unlock
2028
0.27 9.35%
unlock
2029
0.24 11.02%
unlock
2030
0.21 10.32%
unlock

P/S ratio

Current 0.64 36.59%
2026
0.51 19.92%
unlock
2027
0.47 8.16%
unlock
2028
0.42 9.36%
unlock
2029
0.38 11.01%
unlock
2030
0.34 10.33%
unlock

Current Oscar Health Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
Wells Fargo
Locked
Locked
Locked Aug 13 2026
Barclays
Locked
Locked
Locked Aug 07 2026
UBS
Locked
Locked
Locked Aug 07 2026
Barclays
Locked
Locked
Locked Jun 10 2026
Barclays
Locked
Locked
Locked May 26 2026
Baird
Locked
Locked
Locked May 07 2026
UBS
Locked
Locked
Locked May 07 2026
Analyst Rating Date
Locked
Wells Fargo:
Locked
Locked
Aug 13 2026
Locked
Barclays:
Locked
Locked
Aug 07 2026
Locked
UBS:
Locked
Locked
Aug 07 2026
Locked
Barclays:
Locked
Locked
Jun 10 2026
Locked
Barclays:
Locked
Locked
May 26 2026
Locked
Baird:
Locked
Locked
May 07 2026
Locked
UBS:
Locked
Locked
May 07 2026

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today